Terug
Dagbereik
€ 11,52
€ 11,52
52-Weeksbereik
€ 11,52
€ 13,40
Volume
120
50D / 200D Gem.
€ 11,52
/
€ 11,52
Vorige Slotkoers
€ 11,52
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (633 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 0,2 |
| P/B | 0,0 | 2,8 |
| ROE % | 11,9 | 3,7 |
| Net Margin % | 12,1 | 3,9 |
| Rev Growth 5Y % | 0,2 | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 210,57
€ 201,40 – € 220,15
|
250,61B | 1 |
| FY2029 |
€ 196,75
€ 188,17 – € 205,70
|
239,44B | 1 |
| FY2028 |
€ 189,64
€ 181,38 – € 198,27
|
232,67B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | € 58,08 | € 0,27 | -99,5% |
| 2025-11-14 | € 0,20 | € 0,06 | -71,5% |
| 2025-08-12 | € 0,24 | € 0,29 | +23,6% |
| 2025-05-12 | € 0,07 | -€ 0,15 | -303,8% |
| 2025-02-12 | € 0,25 | € 0,34 | +36,8% |
| 2024-11-11 | € 0,32 | € 0,18 | -43,3% |
| 2024-08-09 | € 0,63 | € 2,20 | +250,9% |
| 2024-05-13 | € 0,10 | € 0,03 | -71,9% |
Dividend History
7 yr streakYield
0,02%
Payout Ratio
0,26%
Growth (3Y)
-28,34%
Growth (5Y)
-21,54%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | — | € 0,14 | 2,79% |
| Sep 30, 2025 | Dec 01, 2025 | € 0,18 | 3,14% |
| Mar 31, 2025 | Jun 26, 2025 | € 0,18 | 5,41% |
| Sep 27, 2024 | Dec 02, 2024 | € 0,54 | 5,13% |
| Mar 28, 2024 | Jun 26, 2024 | € 0,43 | 3,20% |
| Sep 28, 2023 | Dec 01, 2023 | € 0,44 | 3,43% |
| Mar 30, 2023 | Jun 28, 2023 | € 0,49 | 3,48% |
| Sep 29, 2022 | Dec 02, 2022 | € 0,45 | 2,30% |
| Mar 30, 2022 | Jun 27, 2022 | € 0,53 | 2,87% |
| Sep 29, 2021 | Dec 03, 2021 | € 0,58 | 2,48% |
| Mar 30, 2021 | Jun 29, 2021 | € 0,59 | 2,55% |
| Sep 29, 2020 | Dec 04, 2020 | € 0,62 | 2,58% |
| Mar 30, 2020 | Jun 24, 2020 | € 0,60 | 2,55% |
| Sep 27, 2019 | Dec 09, 2019 | € 0,60 | 2,62% |
| Mar 27, 2019 | Jun 26, 2019 | € 0,63 | 2,56% |
| Sep 26, 2018 | Dec 07, 2018 | € 0,58 | 2,52% |
| Mar 28, 2018 | Jun 27, 2018 | € 0,61 | 2,52% |
| Sep 27, 2017 | Dec 07, 2017 | € 0,58 | 2,46% |
| Mar 29, 2017 | Jun 28, 2017 | € 0,59 | 2,61% |
| Sep 28, 2016 | Dec 07, 2016 | € 0,65 | 2,58% |
Belangrijkste Punten
Revenue grew 0,24% annually over 5 years — modest growth
Earnings grew 67,49% over the past year
ROE of 11,87% — decent returns on equity
Generating 337,00M in free cash flow
P/E of 0,06 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,64%
Groei
Revenue Growth (5Y)
0,24%
Revenue (1Y)6,88%
Earnings (1Y)67,49%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
11,87%
ROIC5,88%
Net Margin12,13%
Op. Margin11,01%
Veiligheid
Debt / Equity
0,53
Current Ratio1,95
Interest Coverage20,03
Waardering
P/E Ratio
0,06
Forward P/E0,10
P/B Ratio0,01
EV/EBITDA2,59
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,88% | Revenue Growth (3Y) | -2,87% |
| Earnings Growth (1Y) | 67,49% | Earnings Growth (3Y) | 34,57% |
| Revenue Growth (5Y) | 0,24% | Earnings Growth (5Y) | 16,76% |
| Profitability | |||
| Revenue (TTM) | 189,02B | Net Income (TTM) | 22,94B |
| ROE | 11,87% | ROA | 6,47% |
| Gross Margin | 29,81% | Operating Margin | 11,01% |
| Net Margin | 12,13% | Free Cash Flow (TTM) | 337,00M |
| ROIC | 5,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,53 | Current Ratio | 1,95 |
| Interest Coverage | 20,03 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,26% |
| Dividend Growth (3Y) | -28,34% | Dividend Growth (5Y) | -21,54% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,06 | Forward P/E | 0,10 |
| P/B Ratio | 0,01 | P/S Ratio | 0,01 |
| PEG Ratio | -0,27 | Forward PEG | N/A |
| EV/EBITDA | 2,59 | Fwd EV/EBITDA | 1,90 |
| Forward P/S | 0,01 | Fwd Earnings Yield | 1000,00% |
| FCF Yield | 25,33% | ||
| Market Cap | 1,33B | Enterprise Value | 53,88B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 189,02B | 176,86B | 200,34B | 193,82B | 187,22B |
| Net Income | 22,94B | 13,70B | 12,67B | -28,27B | 12,34B |
| EPS (Diluted) | 184,45 | 311,80 | 96,20 | -645,54 | 281,52 |
| Gross Profit | 56,35B | 54,32B | 62,63B | 66,65B | 72,43B |
| Operating Income | 20,81B | 18,62B | 16,39B | -4,45B | 18,89B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 354,62B | 382,02B | 364,17B | 349,50B | 393,34B |
| Total Liabilities | 180,77B | 163,99B | 151,43B | 149,42B | 152,59B |
| Shareholders' Equity | 173,85B | 212,66B | 201,64B | 190,07B | 218,28B |
| Total Debt | 91,34B | 82,89B | 77,07B | 71,23B | 71,85B |
| Cash & Equivalents | 38,79B | 26,37B | 33,08B | 47,72B | 54,27B |
| Current Assets | 200,82B | 239,99B | 205,35B | 202,12B | 205,67B |
| Current Liabilities | 102,82B | 77,35B | 85,15B | 88,84B | 80,45B |